152
Views
45
CrossRef citations to date
0
Altmetric
Review

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements

, , , , &
Pages 2935-2952 | Published online: 22 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rafal Pokrowiecki. (2018) The paradigm shift for drug delivery systems for oral and maxillofacial implants. Drug Delivery 25:1, pages 1504-1515.
Read now
Walter Brand, Cornelle W Noorlander, Christina Giannakou, Wim H De Jong, Myrna W Kooi, Margriet VDZ Park, Rob J Vandebriel, Irene EM Bosselaers, Joep HG Scholl & Robert E Geertsma. (2017) Nanomedicinal products: a survey on specific toxicity and side effects. International Journal of Nanomedicine 12, pages 6107-6129.
Read now
Gabriella Di Felice & Paolo Colombo. (2017) Nanoparticle–allergen complexes for allergen immunotherapy. International Journal of Nanomedicine 12, pages 4493-4504.
Read now
Rodney R. Dietert. (2017) Safety and risk assessment for the human superorganism. Human and Ecological Risk Assessment: An International Journal 23:8, pages 1819-1829.
Read now

Articles from other publishers (41)

Margriet van der Zee, Claudette de Vries, Marc Masa, Marta Morales, Marta Rayo & Ingrid Hegger. (2023) Regulatory aspects of a nanomaterial for imaging therapeutic cells. Drug Delivery and Translational Research.
Crossref
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab & Ahmed O Elzoghby. (2022) Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine 17:22, pages 1721-1745.
Crossref
Valentina Palmieri & Giulio Caracciolo. (2022) Tuning the immune system by nanoparticle–biomolecular corona. Nanoscale Advances 4:16, pages 3300-3308.
Crossref
Haoyao Sun, Kritisha Bhandari, Stephanie Burrola, Jinchang Wu & Wei-Qun Ding. (2022) Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel’s Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis. International Journal of Molecular Sciences 23:9, pages 4773.
Crossref
Eman El-Sayed Khayal, Mohamed Ali Alabiad, Mahmoud Ramadan Elkholy, Amany Mohamed Shalaby, Yousef Nosery & Arwa A. El-Sheikh. (2022) The immune modulatory role of marjoram extract on imidacloprid induced toxic effects in thymus and spleen of adult rats. Toxicology 471, pages 153174.
Crossref
Jeongrae Kim, Yongwhan Choi, Suah Yang, Jaewan Lee, Jiwoong Choi, Yujeong Moon, Jinseong Kim, Nayeon Shim, Hanhee Cho, Man Kyu Shim, Sangmin Jeon, Dong-Kwon Lim, Hong Yeol Yoon & Kwangmeyung Kim. (2022) Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses. Pharmaceutics 14:3, pages 474.
Crossref
Thelvia I. Ramos, Carlos A. Villacis-Aguirre, Katherine V. López-Aguilar, Leandro Santiago Padilla, Claudia Altamirano, Jorge R. Toledo & Nelson Santiago Vispo. (2022) The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development. Pharmaceutics 14:2, pages 247.
Crossref
Raquel Von Hohendorff, Wilson Engelmann & Daniele Weber S. Leal. 2021. Nanotechnology in Medicine. Nanotechnology in Medicine 315 348 .
Shadma Wahab, Mohammad Y. Alshahrani, Md Faruque Ahmad & Hashim Abbas. (2021) Current trends and future perspectives of nanomedicine for the management of colon cancer. European Journal of Pharmacology 910, pages 174464.
Crossref
Juan Gonzalez-Valdivieso, Alessandra Girotti, Jose Schneider & Francisco Javier Arias. (2021) Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation. International Journal of Pharmaceutics 599, pages 120438.
Crossref
Rajesh A. Maheshwari, Dhanya B. Sen, Aarti S. Zanwar & Ashim Kumar Sen. 2021. Nanocarriers: Drug Delivery System. Nanocarriers: Drug Delivery System 173 197 .
Jossana A. Damasco, Saisree Ravi, Joy D. Perez, Daniel E. Hagaman & Marites P. Melancon. (2020) Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine. Nanomaterials 10:11, pages 2186.
Crossref
Christina Giannakou, Margriet V. D. Z. Park, Irene E. M. Bosselaers, Wim H. Jong, Jan Willem Laan, Henk Loveren, Rob J. Vandebriel & Robert E. Geertsma. (2020) Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls. WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref
Christopher A. W. David, Michael Barrow, Patricia Murray, Matthew J. Rosseinsky, Andrew Owen & Neill J. Liptrott. (2020) In Vitro Determination of the Immunogenic Impact of Nanomaterials on Primary Peripheral Blood Mononuclear Cells. International Journal of Molecular Sciences 21:16, pages 5610.
Crossref
Waqas Nawaz, Shijie Xu, Yanlei Li, Bilian Huang, Xilin Wu & Zhiwei Wu. (2020) Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy. Acta Biomaterialia 109, pages 21-36.
Crossref
Martin Himly, Mark Geppert, Sabine Hofer, Norbert Hofstätter, Jutta Horejs‐Höck & Albert Duschl. (2020) When Would Immunologists Consider a Nanomaterial to be Safe? Recommendations for Planning Studies on Nanosafety. Small 16:21, pages 1907483.
Crossref
Megan Branson, Devin Hunt, Elizabeth Putnam & Mark Pershouse. 2020. Information Resources in Toxicology. Information Resources in Toxicology 555 559 .
W.H. De Jong, J.W. Carraway & R.E. Geertsma. 2020. Biocompatibility and Performance of Medical Devices. Biocompatibility and Performance of Medical Devices 123 166 .
Simranjeet Singh, Vijay Kumar, Shivika Datta, Satyender Singh, Daljeet Singh Dhanjal, Renuka Garg, Punmeet Kaur, Kankan Sharma & Joginder Singh. 2020. Model Organisms to Study Biological Activities and Toxicity of Nanoparticles. Model Organisms to Study Biological Activities and Toxicity of Nanoparticles 451 466 .
Barbara Rothen-Rutishauser, Barbara Drasler & Alke Petri-Fink. 2020. Interaction of Nanomaterials with the Immune System. Interaction of Nanomaterials with the Immune System 197 215 .
Changcun Bai & Meng Tang. (2019) Toxicological study of metal and metal oxide nanoparticles in zebrafish. Journal of Applied Toxicology 40:1, pages 37-63.
Crossref
Margareth R.C. Marques, Qiuyi Choo, Mukul Ashtikar, Thais Correa Rocha, Susanne Bremer-Hoffmann & Matthias G. Wacker. (2019) Nanomedicines - Tiny particles and big challenges. Advanced Drug Delivery Reviews 151-152, pages 23-43.
Crossref
Gary Hannon, Joanne Lysaght, Neill J. Liptrott & Adriele Prina‐Mello. (2019) Immunotoxicity Considerations for Next Generation Cancer Nanomedicines. Advanced Science 6:19, pages 1900133.
Crossref
Anne M. DickinsonJessica M. GoddenKateryna LanovykShaheda S. Ahmed. (2019) Assessing the Safety of Nanomedicines: A Mini Review. Applied In Vitro Toxicology 5:3, pages 114-122.
Crossref
Blanka Halamoda-Kenzaoui, Simon Baconnier, Thierry Bastogne, Didier Bazile, Patrick Boisseau, Gerrit Borchard, Sven Even Borgos, Luigi Calzolai, Karin Cederbrant, Gabriella Di Felice, Tiziana Di Francesco, Marina A. Dobrovolskaia, Rogério Gaspar, Belén Gracia, Vincent A. Hackley, Lada Leyens, Neill Liptrott, Margriet Park, Anil Patri, Gert Roebben, Matthias Roesslein, René Thürmer, Patricia Urbán, Valérie Zuang & Susanne Bremer-Hoffmann. (2019) Bridging communities in the field of nanomedicine. Regulatory Toxicology and Pharmacology 106, pages 187-196.
Crossref
Christina Giannakou, Kukka Aimonen, Louis van Bloois, Julia Catalán, Robert E Geertsma, Eric R Gremmer, Wim H de Jong, Peter HJ Keizers, Paul LWJ Schwillens, Rob J Vandebriel & Margriet VDZ Park. (2019) Sensitive method for endotoxin determination in nanomedicinal product samples. Nanomedicine 14:10, pages 1231-1246.
Crossref
Patricia Urbán, Neill J. Liptrott & Susanne Bremer. (2018) Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies. WIREs Nanomedicine and Nanobiotechnology 11:3.
Crossref
H. Denny Liggitt. 2019. Nanotechnology Characterization Tools for Environment, Health, and Safety. Nanotechnology Characterization Tools for Environment, Health, and Safety 65 102 .
Blanka Halamoda‐Kenzaoui, Uwe Holzwarth, Gert Roebben, Alessia Bogni & Susanne Bremer‐Hoffmann. (2018) Mapping of the available standards against the regulatory needs for nanomedicines. WIREs Nanomedicine and Nanobiotechnology 11:1.
Crossref
Valentina Galbiati, Laura Cornaghi, Elisabetta Gianazza, Marco A. Potenza, Elena Donetti, Marina Marinovich & Emanuela Corsini. (2018) In vitro assessment of silver nanoparticles immunotoxicity. Food and Chemical Toxicology 112, pages 363-374.
Crossref
Ayse Basak Engin & A Wallace Hayes. (2018) The impact of immunotoxicity in evaluation of the nanomaterials safety. Toxicology Research and Application 2, pages 239784731875557.
Crossref
Adriele Prina-Mello. 2018. Handbook of Nanomaterials for Cancer Theranostics. Handbook of Nanomaterials for Cancer Theranostics 517 535 .
R.V. House. 2018. Comprehensive Toxicology. Comprehensive Toxicology 873 885 .
Peter Laux, Jutta Tentschert, Christian Riebeling, Albert Braeuning, Otto Creutzenberg, Astrid Epp, Valérie Fessard, Karl-Heinz Haas, Andrea Haase, Kerstin Hund-Rinke, Norbert Jakubowski, Peter Kearns, Alfonso Lampen, Hubert Rauscher, Reinhilde Schoonjans, Angela Störmer, Axel Thielmann, Uwe Mühle & Andreas Luch. (2017) Nanomaterials: certain aspects of application, risk assessment and risk communication. Archives of Toxicology 92:1, pages 121-141.
Crossref
Julia Catalán & Hannu Norppa. (2017) Safety Aspects of Bio-Based Nanomaterials. Bioengineering 4:4, pages 94.
Crossref
C Gutiérrez-Lovera, AJ Vázquez-Ríos, J Guerra-Varela, L Sánchez & M de la Fuente. (2017) The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines. Genes 8:12, pages 349.
Crossref
Maria Dusinska, Jana Tulinska, Naouale El Yamani, Miroslava Kuricova, Aurelia Liskova, Eva Rollerova, Elise Rundén-Pran & Bozena Smolkova. (2017) Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?. Food and Chemical Toxicology 109, pages 797-811.
Crossref
Ksenia J. Groh, Birgit Geueke & Jane Muncke. (2017) Food contact materials and gut health: Implications for toxicity assessment and relevance of high molecular weight migrants. Food and Chemical Toxicology 109, pages 1-18.
Crossref
Margriet V.D.Z. Park, Eric A.J. Bleeker, Walter Brand, Flemming R. Cassee, Merel van Elk, Ilse Gosens, Wim H. de Jong, Johannes A.J. Meesters, Willie J.G.M. Peijnenburg, Joris T.K. Quik, Rob J. Vandebriel & Adriënne J.A.M. Sips. (2017) Considerations for Safe Innovation: The Case of Graphene. ACS Nano 11:10, pages 9574-9593.
Crossref
Barbara Drasler, Phil Sayre, Klaus Günter Steinhäuser, Alke Petri-Fink & Barbara Rothen-Rutishauser. (2017) In vitro approaches to assess the hazard of nanomaterials. NanoImpact 8, pages 99-116.
Crossref
David A Scheinberg, Jan Grimm, Daniel A Heller, Evan P Stater, Michelle Bradbury & Michael R McDevitt. (2017) Advances in the clinical translation of nanotechnology. Current Opinion in Biotechnology 46, pages 66-73.
Crossref